Ocular Therapeutix elects Merilee Raines to Board of Directors

OCULAR THERAPEUTIX, INC

Merilee Raines elected to the Board as Class III director effective September 20, 2021.
She will serve on the Audit Committee and her term expires at the 2023 annual meeting.
Raines received an option to purchase 36,000 shares at $10.02 per share upon election.
She previously served as CFO of IDEXX Laboratories from 2003 to 2013.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Merilee Raines

Director

OCUL · OCULAR THERAPEUTIX, INC

Effective: 2021-09-20
Filed: September 22, 2021, 7:59 PM ET

elected Merilee Raines to serve as a member of the Board to fill a vacancy on the Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Merilee Raines was elected as Director at OCULAR THERAPEUTIX, INC.

Action: elected
Role: Director

Exact text from the filing

elected Merilee Raines to serve as a member of the Board to fill a vacancy on the Board

View on SEC.gov

OCULAR THERAPEUTIX, INC filing history →

Source: SEC EDGAR

accession 0001104659-21-118126

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.